Internet Survey of Awareness and Behavior Related to HPV Vaccination in Japan.
HPV vaccination
Internet survey
cancer screening
cervical cancer
sexual behavior
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
25 Jan 2021
25 Jan 2021
Historique:
received:
21
12
2020
revised:
20
01
2021
accepted:
21
01
2021
entrez:
28
1
2021
pubmed:
29
1
2021
medline:
29
1
2021
Statut:
epublish
Résumé
Recommendations for HPV vaccines were suspended in 2013 due to unfounded safety fears in Japan. We aimed to clarify the differences between vaccinated and unvaccinated females in their awareness, knowledge, and behaviors toward cervical cancer, HPV vaccination and sex. Questionnaires were administered online to women aged 16 to 20. We conducted investigations for the following: awareness, knowledge, and actions for cervical cancer, HPV vaccination, and sexual activity, as well as items related to participants' social background. The survey in 828 girls revealed three points. The first is that more than half of the surveyed Japanese girls had poor knowledge about cervical cancer screening, HPV, or HPV vaccines. The second is that those in the unvaccinated group had a particularly poor knowledge of the subject and tended to have higher sexual activity. The final is that only 0.5% of the girls experienced changes in awareness about sexual activity after vaccination. In conclusion, this is the first large-scale survey analyzing the association between HPV vaccination and sexual activity in Japanese girls. Not only do unvaccinated girls not benefit from vaccines, but they also tend to engage in high-risk sexual behavior, and thus it is even more important to provide information on the effectiveness of vaccines and the usefulness of cancer screening.
Identifiants
pubmed: 33503989
pii: vaccines9020087
doi: 10.3390/vaccines9020087
pmc: PMC7910902
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Japanese Agency for Medical Research and Development
ID : JP15ck0106103
Références
Vaccine. 2019 May 16;37(22):2889-2891
pubmed: 31027925
Ann Epidemiol. 2013 Oct;23(10):620-8
pubmed: 23932068
N Engl J Med. 2020 Oct 1;383(14):1340-1348
pubmed: 32997908
Int Perspect Sex Reprod Health. 2010 Mar;36(1):26-35
pubmed: 20403803
Vaccine. 2019 Jul 26;37(32):4424-4426
pubmed: 31272873
Nihon Eiseigaku Zasshi. 2018;73(2):178-184
pubmed: 29848870
Vaccines (Basel). 2020 Jul 02;8(3):
pubmed: 32630772
J Infect Dis. 2019 Jan 9;219(3):382-390
pubmed: 30299519
Vaccine. 2020 Jan 29;38(5):1025-1031
pubmed: 31786002
J Oncol. 2020 Nov 5;2020:8887672
pubmed: 33204265
BMJ. 2019 Apr 3;365:l1161
pubmed: 30944092
J Adolesc Health. 2015 Feb;56(2):231-7
pubmed: 25620307
Cancer Epidemiol. 2015 Oct;39(5):700-6
pubmed: 26277329
Cancer Sci. 2020 Jun;111(6):2156-2162
pubmed: 32248632
Cancer Sci. 2021 Feb;112(2):839-846
pubmed: 33040433
Vaccine. 2019 May 31;37(25):3310-3316
pubmed: 31064676
Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):641-52
pubmed: 23549400
Vaccines (Basel). 2020 Jul 06;8(3):
pubmed: 32640691
Annu Rev Psychol. 2002;53:133-60
pubmed: 11752482
Papillomavirus Res. 2018 Dec;6:6-10
pubmed: 29807210
Lancet. 2015 Jun 27;385(9987):2571
pubmed: 26122153
Vaccine. 2015 Nov 27;33(48):6629-34
pubmed: 26529071
Am J Public Health. 2000 Oct;90(10):1582-8
pubmed: 11029992
JAMA Oncol. 2017 Jun 1;3(6):833-837
pubmed: 27685805
BMC Public Health. 2019 Jun 25;19(1):821
pubmed: 31238911
Expert Rev Vaccines. 2018 Dec;17(12):1085-1091
pubmed: 30495978
J Womens Health (Larchmt). 2007 Oct;16(8):1224-33
pubmed: 17937576